These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28553437)

  • 21. Prevalence of Low-Cost Generic Program Use in a Nationally Representative Cohort of Privately Insured Adults.
    Pauly NJ; Brown JD
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1162-70. PubMed ID: 26679965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depression and fibromyalgia: treatment and cost when diagnosed separately or concurrently.
    Robinson RL; Birnbaum HG; Morley MA; Sisitsky T; Greenberg PE; Wolfe F
    J Rheumatol; 2004 Aug; 31(8):1621-9. PubMed ID: 15290744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics of High-Cost Patients Diagnosed with Opioid Abuse.
    Shei A; Rice JB; Kirson NY; Bodnar K; Enloe CJ; Birnbaum HG; Holly P; Ben-Joseph R
    J Manag Care Spec Pharm; 2015 Oct; 21(10):902-12. PubMed ID: 26402390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Burden of Undiagnosed Opioid Abuse Among Commercially Insured Individuals.
    Kirson NY; Shei A; Rice JB; Enloe CJ; Bodnar K; Birnbaum HG; Holly P; Ben-Joseph R
    Pain Med; 2015 Jul; 16(7):1325-32. PubMed ID: 25929289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economic cost and epidemiological characteristics of patients with fibromyalgia claims.
    Robinson RL; Birnbaum HG; Morley MA; Sisitsky T; Greenberg PE; Claxton AJ
    J Rheumatol; 2003 Jun; 30(6):1318-25. PubMed ID: 12784409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A systematic review of pharmacoeconomic studies for pregabalin.
    Parker L; Huelin R; Khankhel Z; Wasiak R; Mould J
    Pain Pract; 2015 Jan; 15(1):82-94. PubMed ID: 24815038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The London Fibromyalgia Epidemiology Study: direct health care costs of fibromyalgia syndrome in London, Canada.
    White KP; Speechley M; Harth M; Ostbye T
    J Rheumatol; 1999 Apr; 26(4):885-9. PubMed ID: 10229411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment.
    Mease P
    J Rheumatol Suppl; 2005 Aug; 75():6-21. PubMed ID: 16078356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Real-world evaluation of health-care resource utilization and costs in employees with fibromyalgia treated with pregabalin or duloxetine.
    Harnett J; Margolis J; Cao Z; Fowler R; Sanchez RJ; Mardekian J; Silverman SL
    Pain Pract; 2011; 11(3):217-29. PubMed ID: 21199319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder.
    Aaron LA; Burke MM; Buchwald D
    Arch Intern Med; 2000 Jan; 160(2):221-7. PubMed ID: 10647761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic opioid use in fibromyalgia syndrome: a clinical review.
    Painter JT; Crofford LJ
    J Clin Rheumatol; 2013 Mar; 19(2):72-7. PubMed ID: 23364665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic fatigue, chronic fatigue syndrome, and fibromyalgia. Disability and health-care use.
    Bombardier CH; Buchwald D
    Med Care; 1996 Sep; 34(9):924-30. PubMed ID: 8792781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prevalence of opioid-related major potential drug-drug interactions and their impact on health care costs in chronic pain patients.
    Pergolizzi JV; Ma L; Foster DR; Overholser BR; Sowinski KM; Taylor R; Summers KH
    J Manag Care Spec Pharm; 2014 May; 20(5):467-76. PubMed ID: 24761818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medical resource use and costs among pain patients with potential opioid-tolerability issues.
    Kirson NY; Shei A; Birnbaum HG; Ben-Joseph R; Michna E
    J Opioid Manag; 2014; 10(5):305-10. PubMed ID: 25350472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potentially Unsafe Chronic Medication Use Among Older Adult Chronic Opioid Users.
    Silva Almodovar A; Nahata MC
    Pharmacotherapy; 2019 Feb; 39(2):140-149. PubMed ID: 30636335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of a step-therapy protocol for pregabalin on healthcare utilization and expenditures in a commercial population.
    Udall M; Louder A; Suehs BT; Cappelleri JC; Joshi AV; Patel NC
    J Med Econ; 2013; 16(6):784-92. PubMed ID: 23565813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical and economic burden of fibromyalgia compared with diabetes mellitus and hypertension among Bedouin women in the Negev.
    Doron Y; Peleg R; Peleg A; Neumann L; Buskila D
    Fam Pract; 2004 Aug; 21(4):415-9. PubMed ID: 15249530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic fatigue syndrome and fibromyalgia in Canada: prevalence and associations with six health status indicators.
    Rusu C; Gee ME; Lagacé C; Parlor M
    Health Promot Chronic Dis Prev Can; 2015 Mar; 35(1):3-11. PubMed ID: 25811400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional Status, Quality of Life, and Costs Associated With Fibromyalgia Subgroups: A Latent Profile Analysis.
    Luciano JV; Forero CG; Cerdà-Lafont M; Peñarrubia-María MT; Fernández-Vergel R; Cuesta-Vargas AI; Ruíz JM; Rozadilla-Sacanell A; Sirvent-Alierta E; Santo-Panero P; García-Campayo J; Serrano-Blanco A; Pérez-Aranda A; Rubio-Valera M
    Clin J Pain; 2016 Oct; 32(10):829-40. PubMed ID: 26633691
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.